about
Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indicationsPeroxisome Proliferator-Activated Receptors in Female Reproduction and FertilityMicroRNAs Related to Polycystic Ovary Syndrome (PCOS)MiR-133b regulates the expression of the Actin protein TAGLN2 during oocyte growth and maturation: a potential target for infertility therapy.Polycystic ovary syndrome induced by exposure to testosterone propionate and effects of sympathectomy on the persistence of the syndrome.Exposure of female macaques to Western-style diet with or without chronic T in vivo alters secondary follicle function during encapsulated 3-dimensional cultureWestern-style diet, with and without chronic androgen treatment, alters the number, structure, and function of small antral follicles in ovaries of young adult monkeysMaternal High-Fat Diet-Induced Loss of Fetal Oocytes Is Associated with Compromised Follicle Growth in Adult Rat Offspring.miR-483 is Down-Regulated in Polycystic Ovarian Syndrome and Inhibits KGN Cell Proliferation via Targeting Insulin-Like Growth Factor 1 (IGF1)The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Xiao-Yao-San, a Chinese Medicine Formula, Ameliorates Chronic Unpredictable Mild Stress Induced Polycystic Ovary in Rat.Neuronal androgen receptor: Molecular gateway to polycystic ovary syndrome?Phospholipase C-related but catalytically inactive proteins regulate ovarian follicle development.Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients.Telomere length is short in PCOS and oral contraceptive does not affect the telomerase activity in granulosa cells of patients with PCOS.
P2860
Q22242884-E44A0F27-7E46-43F8-9550-C8213BD5250BQ26738962-9BFC7838-1511-49D1-8788-079AB5BE383BQ27025580-97EA076A-CA49-4E82-B4E8-76A9A4418901Q33800459-F2232DDE-D1B0-495A-876B-2F70328716FDQ33891765-64980326-BC15-4172-AE26-FF3E212905B5Q35088832-E68AF2E5-5FCC-4DC8-BAF8-C0339ACCAE08Q36767622-74CA3504-C5F6-4C1D-86BA-8DD98056B8ACQ36883930-3CCD9E0F-7A95-47F0-9B3F-BC7D5D31C0D0Q37292470-974FD0B8-1F41-4A04-901F-BF983C0E98D6Q41640666-CDC710A5-4DFF-4DB8-A8D6-0C0254393807Q42028535-3F3BA2B4-E2EE-433E-92AA-7D8BFBD2FCC7Q42290715-E06A814E-4002-4407-AAB2-8D29BE047EC6Q47809993-DA95AECF-B5D6-4BF0-9BB2-411A9D25810DQ50856309-7F89CC66-8A69-4769-8506-E768F1AC676CQ52772537-9D6181C4-D7C2-45A7-9EFD-B92378B5A761
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Disordered follicle development
@ast
Disordered follicle development
@en
Disordered follicle development
@nl
type
label
Disordered follicle development
@ast
Disordered follicle development
@en
Disordered follicle development
@nl
prefLabel
Disordered follicle development
@ast
Disordered follicle development
@en
Disordered follicle development
@nl
P2860
P3181
P1476
Disordered follicle development
@en
P2093
Heidi Cook-Andersen
R. Jeffrey Chang
P2860
P3181
P356
10.1016/J.MCE.2012.07.011
P407
P577
2013-07-05T00:00:00Z